Health Condition 1: N970- Female infertility associated withanovulation
Conditions
Interventions
Intervention1: Administration of Tablet Clomiphene Citrate: Administration of Tablet Clomiphene Citrate 50mg per orally from Day 2 of menstrual cycle till day 7 of cycle
Dose is escalated to 100mg a
Sponsors
Dr P Santhosh
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age: 18 - 35 years. 2. Body mass index (BMI): 18 - 30 kg/m2. 3. Patients with normogonadotropichypogonadism (WHO type 2). 4. Normal semen analysis of the husband. 5. Normal serum Prolactin 6.Consenting to participate in the study
Exclusion criteria
Exclusion criteria: 1.Thyroid dysfunction, active liver diseases. 2. Local diseases as endometriosis, ovarian tumors, hydro- or pyosalpinx etc. 3. Patients with previous history of Ovulation induction. 4. Patients with previous history of ovarian drilling. 5.Any Medical complications 6.Any Obstetrical complications 7. Any contraindication for Tab Clomiphene citrate or Tab Tamoxifen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of ovulationTimepoint: Follicular scan from Day 11 of menstrual cycle till Day14 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Estimation of Endometrial thickness 2 Incidence of Pregnancy 3 Outcome of PregnancyTimepoint: 1 Estimation of Endometrial thickness from Day 11 to Day 14 of menstrual cycle 2 Urine Pregnancy Test on 28 day of menstrual cycle 3 Outcome of Pregnancy at 14 weeks of gestation | — |
Countries
India
Contacts
Public ContactDr P Santhosh
Karnataka Medical College and Research Institute Vidyanagar Hubballi
Outcome results
None listed